Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics.
about
Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South AfricaEfficacy and reinfection with soil-transmitted helminths 18-weeks post-treatment with albendazole-ivermectin, albendazole-mebendazole, albendazole-oxantel pamoate and mebendazoleAssessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemicIn vitro and in vivo efficacy of Monepantel (AAD 1566) against laboratory models of human intestinal nematode infectionsQuality of medicines commonly used in the treatment of soil transmitted helminths and giardia in ethiopia: a nationwide surveyEfficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in MiceEffect of Two or Six Doses 800 mg of Albendazole Every Two Months on Loa loa Microfilaraemia: A Double Blind, Randomized, Placebo-Controlled TrialpH-sensitive magnetic alginate-chitosan beads for albendazole delivery.A novel pH-sensitive magnetic alginate-chitosan beads for albendazole delivery.Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.Assessment of acute oral and dermal toxicity of 2 ethyl-carbamates with activity against Rhipicephalus microplus in ratsCysteine proteinases from papaya (Carica papaya) in the treatment of experimental Trichuris suis infection in pigs: two randomized controlled trials.Application of ultra-performance columns in high-performance liquid chromatography for determination of albendazole and its metabolites in turkeys.A simple LC-MS/MS method to determine plasma and cerebrospinal fluid levels of albendazole metabolites (albendazole sulfoxide and albendazole sulfone) in patients with neurocysticercosis.Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme.Treatment with anthelminthics during pregnancy: what gains and what risks for the mother and child?Preclinical studies on the pharmacokinetics, safety, and toxicology of oxfendazole: toward first in human studies.Brain Penetration and Efficacy of Different Mebendazole Polymorphs in a Mouse Brain Tumor Model.The bladder carcinoma secondary to schistosoma mansoni infection: A case report with review of the literature.Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine.Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose poleSuccessful Antiparasitic Treatment for Cysticercosis is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model.Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions.Acyclic Cucurbit[n]uril-Type Molecular Container Enables Systemic Delivery of Effective Doses of Albendazole for Treatment of SK-OV-3 Xenograft TumorsDNA Damage Response Is Involved in the Developmental Toxicity of Mebendazole in Zebrafish Retina.CYP2J2 and CYP2C19 are the major enzymes responsible for metabolism of albendazole and fenbendazole in human liver microsomes and recombinant P450 assay systems.Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazoleSubchronic toxicity study in rats of two new ethyl-carbamates with ixodicidal activity.Exposure of Heligmosomoides polygyrus and Trichuris muris to albendazole, albendazole sulfoxide, mebendazole and oxantel pamoate in vitro and in vivo to elucidate the pathway of drug entry into these gastrointestinal nematodes.Current bioanalytical methods for pharmacokinetic studies of drugs used in neglected tropical diseases.Mutual action of anticancer and antiparasitic drugs: are there any shared targets?A review of pharmacokinetic drug-drug interactions with the anthelmintic medications albendazole and mebendazole.Uncertainties in diagnosis, treatment and prevention of trichinellosis.Plasma pharmacokinetics and muscle residue dynamics of mebendazole in Carassius auratus.In Vitro and In Vivo Drug Interaction Study of Two Lead Combinations, Oxantel Pamoate plus Albendazole and Albendazole plus Mebendazole, for the Treatment of Soil-Transmitted Helminthiasis.Effect of squalane on mebendazole-loaded Compritol® nanoparticles.Survey of Obstetrician-Gynecologists in the United States About Taeniasis and Cysticercosis.Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluidAlbendazole induces oxidative stress and DNA damage in the parasitic protozoan Giardia duodenalis.An insect-tapeworm model as a proxy for anthelminthic effects in the mammalian host.
P2860
Q24805329-67ED345E-C056-4694-90C1-BE2BEC88BC64Q27329637-25371FCB-BD0C-4E62-B58B-C776A9988B3BQ28477545-D511BF74-60CE-49E2-BFEF-C71A8F7AADFBQ28478581-13154356-F85A-447E-AE54-6E7C448F1E29Q28542519-2F0E0587-3E80-4A86-B6B6-C3264088F7AEQ28547778-6D00DEB1-54CF-4621-9708-5A7BE11060D5Q28550715-84D9D1CE-9666-4EC4-905F-00CFDE2CBC63Q33529830-A0F20789-94BE-4F50-8BA9-497619EC6B40Q33546564-C5D4BC3F-BA4F-491D-915F-EB97CB02D9C1Q33642023-7B780F18-69DF-4D13-80A9-DC054D9F8CB2Q33657096-F450C5CB-0ECB-4E02-B736-1CA18A6A711FQ33726418-D48B45A8-02B0-4243-9262-E473F0DEDBEFQ33811849-9820F372-ADD7-4ED3-AF68-970251E605A5Q33948162-432DA87C-8175-4269-8660-B6F9EF75E48DQ35170361-5DE1D808-2B1F-4BD3-8926-4358870C93A3Q35228681-70E1A279-A169-4BE8-A9FC-07D188C28687Q35536978-F06FE52E-D71F-4E1C-9B8B-D2DACB36AF5FQ35920872-B2725055-DBE3-4E58-98CD-D37D3F4348A7Q35929909-D717F53C-F127-410D-B4AE-8479E5CCAD54Q36026159-E40C243A-A7E6-4EEF-8D40-45ED8B4E05A1Q36125948-7BD99BD6-11C3-4FFB-A3E3-6A0B43AFCE20Q36359310-B11C51F7-8818-4090-8864-C8732A8A474CQ36380868-6760ABB3-6373-4057-8780-EFB806E74BABQ36665183-E19923D5-94C1-41C4-AC64-FB63ED37BF5BQ36680834-E6BC94BD-0FD3-492A-A5EE-18721C83EA36Q37263390-34A0846A-EC84-4D0D-9987-78DEEE94E0B8Q37471097-99A853B7-B4D9-4DDC-9FF3-4CCC169B990AQ37730841-4B3BAA63-9C78-4691-956B-2AFE1375CD0FQ37734853-EF3EAD84-7E09-4E40-AA35-0E80DD08809CQ38235444-2AC5F760-5C77-44E2-A71A-04700FEF08FFQ38294631-7BCC731E-DC7D-440D-B288-4A44BE324061Q38359488-F2010C88-CB90-48E5-B654-7CC778E5984EQ38560932-28F64BC7-055F-4BEE-AFDA-78E77D3910A4Q38841106-9C558FFE-8F92-47F3-BD40-96E37AA770CFQ38955207-38A53098-501E-4592-B432-80AE4C12539AQ38997074-3EF110D5-BB23-4836-B830-FA8C677E07DFQ39026109-3126D280-F987-42CC-B94C-5B512910A2D9Q40600560-1ABAC846-5CF5-4E46-8414-B3BD33515175Q40614249-84ED9F62-E1B8-4AE5-A5B7-BD69B24A88B6Q41038140-FCEB1987-0AA3-47C4-80B5-230FE50598E7
P2860
Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@ast
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@en
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@nl
type
label
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@ast
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@en
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@nl
prefLabel
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@ast
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@en
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@nl
P1433
P1476
Albendazole, mebendazole and p ...... toxicity and pharmacokinetics.
@en
P2093
P304
P356
10.1016/S0001-706X(03)00031-7
P577
2003-05-01T00:00:00Z